Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
15.12.25
/
50%
€878.60
Target price
15.12.26
-
Performance (%)
-10.36%
Price
17.04.26
€787.60
Summary
This prediction is currently active. The price of Eli Lilly Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.36%. This prediction currently runs until 15.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -1.685% | -1.685% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for LLY provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€881.10
13.12.25
13.12.25
€975.54
13.12.26
13.12.26
-10.61%
17.04.26
17.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€678.00
08.04.25
08.04.25
€810.30
08.04.26
08.04.26
20.34%
09.04.26
09.04.26